Advertisement
Research Article| Volume 276, ISSUE 1-2, P130-132, January 15, 2009

Download started.

Ok

Opticospinal multiple sclerosis in Iran

      Abstract

      Clinical course, magnetic resonance imaging (MRI) findings and cerebrospinal fluid data (CSF) on 20 patients among 520 with clinically definite multiple sclerosis (MS) according to the criteria of Poser et al., with opticospinal clinical presentation above 5 years and mean disease duration of 8±4.4 years were reviewed. The prevalence rate was 3.8%. The clinical course was relapsing-remitting (RR) for all patients. The mean age of onset was 24±8.2 years. The gender ratio was 2.3:1 female:male. First clinical presentation was spinal signs in 12 (60%), optic neuritis in 7 (35%) and simultaneous involvement of both eyes in 1 (5%) patient. No transverse myelitis (TM), sustained severe optic neuritis (SSON) or minor brain stem signs were recorded. No conversion to conventional MS (CMS) or secondary progressive MS (SPMS) was identified during the study period and no case had positive family history for the disease. The yearly number of attacks was 0.66±0.84, with mean Kurtzke expanded disability status scale (EDSS) of 2.5±1.2. All patients had 1 to 5 hemispheral T2 lesions in brain MRI, non-fulfilled Barkhof criteria for brain lesions. All had preventricular and 14 (70%) had juxtacortical lesions. None had gadolinium T1 enhanced lesions. No involvement of the brainstem or cerebellar structures was detected. Fifteen had 1 cervical lesion, five had 2 and four had 1 concomitant thoracic cord signal, all extending below three vertebral segments in sagittal planes with peripheral white matter location on the axial planes. Spinal fluid contained normal cell and protein with negative oligoclonal bands (OB).

      Keyword

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lucchinetti C.
        • Bruck W.
        • Parisi J.
        • Scheithauer B.
        • Rodriguez M.
        • Lassmann H.
        Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
        Ann Neurol. 2000; 47: 707-717
        • Heard R.N.
        The spectrum of multiple sclerosis.
        Curr Allergy Asthma Rep. 2007; 7: 280-304
        • Compston A.
        Complexity and heterogeneity in demyelinating disease.
        Brain. 2007; 130: 1178-1180
        • Lublin F.D.
        • Reingold S.C.
        Defining the clinical course of multiple sclerosis.
        Neurology. 1996; 46: 907-911
        • Kuroiwa Y.
        • Igata A.
        • Itahara K.
        • Koshijima S.
        • Tsubaki T.
        Nationwide survey of multiples sclerosis in Japan: clinical analysis of 1,084 cases.
        Neurology. 1975; 25: 845-851
        • Kira J.
        • Kanai T.
        • Nishimura Y.
        • Yamasaki K.
        • Matsushita S.
        • Kawano Y.
        • et al.
        Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.
        Ann Neurol. 1996; 40: 569-574
        • Yamasaki K.
        • Horiuchi I.
        • Minoliara M.
        • Kawano Y.
        • Ohyagi Y.
        • Yamada T.
        • et al.
        HLADPB low asterisk0501 associated opticospinal multiple sclerosis. Clinical, neuro imaging and immunogenetic studies.
        Brain. 1999; 122: 1689-1696
        • Fukazawa T.
        • Kikuchi S.
        • Sasaki H.
        • Hamada K.
        • Hamada T.
        • Miyasaka K.
        • et al.
        The significance of oligoclonal bands in multiple sclerosis in Japan; relevance of immunogenetic backgrounds.
        J Neurol Sci. 1998; 158: 209-214
        • Kurtzke J.F.
        Rating neurological impairment in multiple sclerosis: an expanded disability status scale(EDSS).
        Neurology. 1983; 33: 1444-1452
        • Kira J.
        Multiple sclerosis in the Japanese population.
        Lancet Neurol. 2003; 2: 117-127
        • Zhao B.X.
        • Liu X.Q.
        • Guo Y.P.
        • Yang Y.C.
        • Huang H.F.
        Multiple sclerosis. A clinical study of 70 cases.
        Eur Neurol. 1981; 20: 394-400
        • Lau K.K.
        • Wong L.K.
        • Li L.S.
        • Chan Y.W.
        • Li H.L.
        • Wong V.
        Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey.
        Hong Kong Med J. 2002; 8: 77-80
        • Hung T.P.
        • Landsborough D.
        • His M.S.
        Multiple sclerosis amongst Chinese in Taiwan.
        J Neurol Sci. 1976; 27: 459-484
        • Das A.
        • Puvanendran K.
        A retrospective review of patients with clinically definite multiple sclerosis.
        Ann Acad Med Singapore. 1998; 27: 204-209
        • Jitpimolmard S.
        • Vejjajiva A.
        Clinical features and clinical course of multiple sclerosis in Thai patients: a report of 50 cases.
        J Med Assoc Tha. 1994; 77: 239-243
        • Kurtzke J.F.
        • Park C.S.
        • Oh S.J.
        Multiple sclerosis in Korea. Clinical features and prevalence.
        J Neurol Sci. 1968; 6: 463-481
        • Tan C.T.
        Multiple sclerosis in Malaysia.
        Arch Neurol. 1988; 45: 624-627
        • Osoegawa M.
        • Nino M.
        • Kikuchi S.
        • Murai H.
        • Fukazawa T.
        • Minohara M.
        • et al.
        Comparison of the clinical courses of the opticospinal and conventional multiple sclerosis in Japan.
        Intern Med. 2005; 44: 934-938
        • Yaqub B.A.
        • Daif A.K.
        Multiple sclerosis in Saudi Arabia.
        Neurology. 1988; 38: 621-623
        • Al-Din A.S.
        • el-Khateeb M.
        • Kurdi A.
        • Mubaidin A.
        • Wriekat A.
        • al-Shehab A.
        • et al.
        Multiple sclerosis in Arabs in Jordan.
        J Neurol Sci. 1995; 131: 144-149
        • Al-Din A.S.
        Multiple sclerosis in Kuwait: clinical and epidemiological study.
        J Neurol Neurosurg Psychiatry. 1986; 49: 928-931
        • Daif A.K.
        • Al-Rajeh S.
        • Awada A.
        • Al Bunyan M.
        • Ogunniyi A.
        • Abduljabar M.
        • et al.
        Pattern of presentation of multiple sclerosis in Saudi Arabia: analysis based on clinical and paraclinical features.
        Eur Neurol. 1998; 39: 182-186
        • Al-Araji A.
        • Mohammed A.I.
        Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?.
        J Neurol Sci. 2005; 15: 67-71
        • Kalanie H.
        • Gharagozli K.
        • Kalanie A.R.
        Multiple sclerosis: report on 200 cases from Iran.
        Mult Scler. 2003; 9: 36-38
        • Poser C.M.
        • Paty D.W.
        • Scheinberg L.C.
        • McDonald I.W.
        • Davis F.A.
        • Ebers C.G.
        • et al.
        New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
        Ann Neurol. 1983; 13: 227-231
        • Barkhof F.
        • Filippi M.
        • Miller D.H.
        • Scheltens P.
        • Campi A.
        • Polman C.H.
        • et al.
        Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
        Brain. 1997; 120: 2059-2069
        • Wingerchuk D.M.
        • Lennon V.A.
        • Pittock S.J.
        • Lucchinetti C.F.
        • Weinshenker B.G.
        Revised diagnostic criteria for neuromyelitis optica.
        Neurology. 2006; 66: 1485-1489
        • Tartaglino L.M.
        • Croul S.E.
        • Flanders A.E.
        • Sweeney J.D.
        • Schwartzman R.J.
        • Liem M.
        • et al.
        Idiopathic acute transverse myelitis: MR imaging findings.
        Radiology. 1996; 201: 661-669
        • Kalanie H.
        Histocompatibility(HLA) association with multiple sclerosis in Iran.
        in: Kamgooyan M. Sadeghian H. Kalanie A.R. Mult Scler. 6. 2000: 317-319
        • Misu T.
        • Fujihara K.
        • Nakashima I.
        • Miyazawa L.
        • Okita N.
        • Takase S.
        • et al.
        Pure opticospinal form of multiple sclerosis in Japan.
        Brain. 2002; 125: 2460-2468
        • Nakashima I.
        • Fukazawa T.
        • Ota K.
        • Nohara C.
        • Warabi Y.
        • Ohashi T.
        • et al.
        Two subtypes of opticospinal form of multiple sclerosis in Japan: clinical and laboratory features.
        J Neurol. 2007; 254: 488-492
        • Matsuoka T.
        • Matsushita T.
        • Osoegawa M.
        • Ochi H.
        • Kawano Y.
        • Mihara F.
        • et al.
        Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings.
        J Neurol Sci. 2008; 266: 115-125